96 related articles for article (PubMed ID: 30864368)
1. Immunohistochemical Expression of Epidermal Growth Factor Receptor in Hepatocellular Carcinoma.
Nikolova D; Chalovska V; Ivanova MG; Nikolovska E; Volkanovska A; Orovchanec N; Kunovska SK; Petrushevska G; Janevska V
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2018 Dec; 39(2-3):21-28. PubMed ID: 30864368
[TBL] [Abstract][Full Text] [Related]
2. Epidermal Growth Factor Receptor immunohistochemical expression in hepatocellular carcinoma without Epidermal Growth Factor Receptor exons 18-21 mutations.
Nikolova D; Trajkovska M; Trpcevska EN; Eftimov A; Jovanovik R; Janevska V
Rom J Intern Med; 2022 Sep; 60(3):153-159. PubMed ID: 35476635
[No Abstract] [Full Text] [Related]
3. MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patients.
Wang RY; Chen L; Chen HY; Hu L; Li L; Sun HY; Jiang F; Zhao J; Liu GM; Tang J; Chen CY; Yang YC; Chang YX; Liu H; Zhang J; Yang Y; Huang G; Shen F; Wu MC; Zhou WP; Wang HY
Gastroenterology; 2013 Dec; 145(6):1436-48.e1-12. PubMed ID: 23933603
[TBL] [Abstract][Full Text] [Related]
4. Cx32 exerts anti-apoptotic and pro-tumor effects via the epidermal growth factor receptor pathway in hepatocellular carcinoma.
Xiang Y; Wang Q; Guo Y; Ge H; Fu Y; Wang X; Tao L
J Exp Clin Cancer Res; 2019 Apr; 38(1):145. PubMed ID: 30947731
[TBL] [Abstract][Full Text] [Related]
5. [Expression and significance of EGF mRNA and EGFR mRNA in hepatocellular carcinoma].
Zhao YN; Cao J; Wu FX; Ou C; Yuan WP; Mo QG; Wei W; Li Y; Su JJ; Liang AM
Ai Zheng; 2004 Jul; 23(7):762-6. PubMed ID: 15248908
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical assessment of angiogenesis in hepatocellular carcinoma and surrounding cirrhotic liver tissues.
Deli G; Jin CH; Mu R; Yang S; Liang Y; Chen D; Makuuchi M
World J Gastroenterol; 2005 Feb; 11(7):960-3. PubMed ID: 15742396
[TBL] [Abstract][Full Text] [Related]
7. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
8. [Immunohistochemical studies on epidermal growth factor receptor in hepatocellular carcinoma].
Tanaka H
Nihon Shokakibyo Gakkai Zasshi; 1991 Feb; 88(2):138-44. PubMed ID: 1851518
[TBL] [Abstract][Full Text] [Related]
9. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk between EGFR and p53 in hepatocellular carcinoma.
Cioca A; Cimpean A; Ceausu R; Fit AM; Zaharie T; Al-Hajjar N; Puia V; Raica M
Asian Pac J Cancer Prev; 2014; 15(19):8069-73. PubMed ID: 25338986
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived growth factor receptor α in hepatocellular carcinoma is a prognostic marker independent of underlying liver cirrhosis.
Yu JH; Kim JM; Kim JK; Choi SJ; Lee KS; Lee JW; Chang HY; Lee JI
Oncotarget; 2017 Jun; 8(24):39534-39546. PubMed ID: 28465473
[TBL] [Abstract][Full Text] [Related]
12. Expression of heparanase in hepatocellular carcinoma has prognostic significance: a tissue microarray study.
Chen G; Dang YW; Luo DZ; Feng ZB; Tang XL
Oncol Res; 2008; 17(4):183-9. PubMed ID: 18773863
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical characteristics of hepatocellular carcinoma in non-cirrhotic livers.
Witjes CD; ten Kate FJ; Verhoef C; de Man RA; IJzermans JN
J Clin Pathol; 2013 Aug; 66(8):687-91. PubMed ID: 23585667
[TBL] [Abstract][Full Text] [Related]
14. Serine/arginine rich splicing factor 2 expression and clinic pathological features indicating a prognostic factor in human hepatocellular carcinoma patients.
Wang P; Guo L; Li K; Ning S; Shi W; Liu Z; Chen Y
Cancer Biomark; 2018 Feb; 21(3):681-687. PubMed ID: 29278882
[TBL] [Abstract][Full Text] [Related]
15. COX-2 expression in hepatocellular carcinoma is an initiation event; while EGF receptor expression with downstream pathway activation is a prognostic predictor of survival.
Foster J; Black J; LeVea C; Khoury T; Kuvshinoff B; Javle M; Gibbs JF
Ann Surg Oncol; 2007 Feb; 14(2):752-8. PubMed ID: 17146741
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma].
Chen G; Luo DZ; Wang Y; Liao ZL; Zhang MY
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):113-7. PubMed ID: 17493386
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma--survival and clinical characteristics in relation to various histologic molecular markers in Western patients.
Schöniger-Hekele M; Hänel S; Wrba F; Müller C
Liver Int; 2005 Feb; 25(1):62-9. PubMed ID: 15698400
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemistry panel segregates molecular types of hepatocellular carcinoma in Brazilian autopsy cases.
Felipe-Silva A; Wakamatsu A; Dos Santos Cirqueira C; Alves VA
World J Gastroenterol; 2016 Jul; 22(27):6246-56. PubMed ID: 27468214
[TBL] [Abstract][Full Text] [Related]
19. Progesterone receptor membrane component 1 as a potential prognostic biomarker for hepatocellular carcinoma.
Tsai HW; Ho CL; Cheng SW; Lin YJ; Chen CC; Cheng PN; Yen CJ; Chang TT; Chiang PM; Chan SH; Ho CH; Chen SH; Wang YW; Chow NH; Lin JC
World J Gastroenterol; 2018 Mar; 24(10):1152-1166. PubMed ID: 29563759
[TBL] [Abstract][Full Text] [Related]
20. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
[No Abstract] [Full Text] [Related]
[Next] [New Search]
